Market Research Report
Clinical Chemistry Analyzers - Global Market Outlook (2018-2027)
|Published by||Stratistics Market Research Consulting||Product code||932683|
|Published||Content info||155 Pages
Delivery time: 2-3 business days
|Clinical Chemistry Analyzers - Global Market Outlook (2018-2027)|
|Published: March 1, 2020||Content info: 155 Pages||
According to Stratistics MRC, the Global Clinical Chemistry Analyzers market is accounted for $11,114.09 million in 2018 and is expected to reach $21,308.36 million by 2027 growing at a CAGR of 7.5% during the forecast period. Some of the key factors propelling the market growth are the advancements in the healthcare sector, rising occurrence of lifestyle diseases, and increasing number of geriatric population. However, the requirement of high initial investment is the restraining factor for the growth of the market.
Clinical chemistry analyzers are laboratory devices used for the calculation of the concentration of certain substances contained by samples of serum, plasma, urine and other body fluids. Substances like certain metabolites, electrolytes, proteins, and drugs can be analyzed through these instruments.
By product, the reagents segment is expected to grow at a significant market share during the forecast period as they are highly cost efficient and ensures negligible variation in performance. On the basis of geography, North America is anticipated to hold considerable market share during the forecast period which is attributed to the supportive government initiatives and the implementation of guidelines released by healthcare organizations present across this region.
Some of the key players in Clinical Chemistry Analyzers Market include Siemens Healthineers, Thermo Fisher Scientific, Inc, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Randox Laboratories Ltd, Mindray Medical International Limited, Ortho Clinical Diagnostics, Danaher Corporation, Horiba Ltd, Elitech Group.
End Users Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: